Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs
A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be relevant for treating metastatic cancer. This is because actionable DNA errors remain remarkably stable over time, despite treatment with drugs. This discovery was made by Dutch researchers in a study led by the Netherlands Cancer Institute. The researchers used data from the Hartwig Medical Database for their research. They published their findings on August 9 online in the scientific journal Nature Medicine.
More information
- Publication in Nature: Joris van de Haar et al, ‘Limited evolution of the actionable metastatic cancer genome under therapeutic pressure’
- Paper in The Journal of Molecular Diagnostics: Clinical validation of Whole Genome Sequencing for cancer diagnostics
- Video voor treating physicians and pathologists about one-time analysis of the entire tumor DNA
- More information about WGS and the extensive DNA test for Cancer Diagnostics: OncoAct.nl
All news
Also read
Why genomes need clinical data: new Nature study uses Hartwig real world data to test a prostate cancer biomarker
Understanding prostate cancer’s clinical heterogeneity A new study in Nature investigates the mutational processes behind prostate cancer’s clinical heterogeneity and …
22 impactful scientific publications in 2022
In 2022, research groups from all over the world published 22 scientific papers in which data from the Hartwig Medical …
Breast cancer awareness month
October is the international breast cancer awareness month. Breast cancer is the second most common type of cancer, and the …
The number of WGS samples Hartwig Medical Foundation has is quite unique in the research field and is rapidly growing. It amounted to 3.500 samples when we started and it’s already over 5.000 now.